This disorder is associated with other chronic diseases, such as hypertension, stroke, depression, anxiety, and cardiovascular diseases (2, 5, 6)
Individual patient factorsincluding the severity of infection, diabetes control, hydration status, and tolerance to gastrointestinal side effectsshould guide clinical decision-making
9 , e018023 (2020)
Because semaglutide's half-life is approximately one week, twice-weekly injections would create unpredictable and dangerously high drug concentrations
Additionally, studies comparing Melanotan II and PT-141 suggest both peptides may help treat sexual dysfunction, including erectile dysfunction (ED) and low libido
What the Research Says The bottom line: No randomized controlled trial has tested weekly semaglutide doses below 0.25 mg for weight loss, cardiovascular benefit, or metabolic outcomes